The New Health Report is a series of analytical surveys of the drug development world commissioned by Quintiles, the leading integrated biopharmaceutical services company. This thought leadership initiative gauges trends, attitudes and relational dynamics among various stakeholder groups, including physicians, biopharma executives, managed care executives and patients.
Quintiles turned to Signal to produce the presentation and communication vehicles for the survey findings, beginning with the first New Health Report in 2011. Signal developed an iconography system for the stakeholder groups and the visual execution for the many infographics and key findings diagrams. Deliverables included report documents in print and PDF formats and a detailed microsite.
The 2011 New Health Report drew a great deal of trade media attention and online buzz within the biopharma industry. Quintiles engaged Signal again for the 2012 edition, which expanded with the addition of investors as a stakeholder group as well as comparisons of responses from the U.S. and the U.K.